Owners, management and financials
CVR: 45346951
Previous names: Asprita ApS
DKK 23,793
Gross profit
Net result: DKK 18,491
ASPRITA LIMITED (100%)
CVR · view owners
Simon James Dorris
CVR · view management
Active
Founded 20 January 2025
CVR · view overview
1 employee
Annual report 2025 · average
Name registered: Parity Pharma ApS
CVR · 09/07/2026
View the full event history
Parity Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2025. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Asprita ApS. The management consists of Simon James Dorris. The company is owned by ASPRITA LIMITED. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 23,793 and a net result of DKK 18,491. Equity in the 2025 report amounted to DKK 58,491.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202520/01/2025 – 31/12/2025 | 24 t. | 18 t. | 445 t. | 58 t. | 1 |
Compared to 404 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Parity Pharma ApS is 45346951.
Parity Pharma ApS is owned by ASPRITA LIMITED.
The management of Parity Pharma ApS consists of Simon James Dorris.
In 2025, Parity Pharma ApS reported a gross profit of DKK 23,793.
Parity Pharma ApS had an average of 1 employee in the 2025 financial year according to the annual report.
Parity Pharma ApS was founded on 20 January 2025.
Claim this page to add your logo and social links. Free to get started.
Address changed to Rådhusstræde 15, 1466 København K (October 13, 2026).
On July 9, 2026, the company changed its name from Asprita ApS to Parity Pharma ApS.
Parity Pharma ApS has published its annual report for 2025. Gross profit came to DKK 23,793, and the net result was DKK 18,491.
As of August 29, 2025, is registered as an owner of Parity Pharma ApS with an ownership share of 100%.
As of January 20, 2025, Simon James Dorris is registered as director of Parity Pharma ApS.
Parity Pharma ApS was founded on January 20, 2025.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 37626619
CVR 41183144
CVR 35451307
CVR 36392398
CVR 14479880
